Table 4.
Posterior mean (posterior standard deviation) of expected survival for patients receiving implantable cardioverter defibrillators (ICDs) and anti‐arrhythmic drugs (AAD), by sex.
| Parameter | Survival models | |||
|---|---|---|---|---|
| Weibull | Cox‐like | Poly‐Weibull | Poly‐Gompertz | |
| Overall | ||||
| ICD mean survival | 8.88 (0.71) | 9.41 (0.78) | 9.18 (0.75) | 11.54 (1.03) |
| AAD mean survival | 7.06 (0.73) | 7.43 (0.81) | 6.06 (0.80) | 7.62 (1.15) |
| Life years gained | 1.82 (0.49) | 1.98 (0.53) | 3.12 (0.61) | 3.92 (0.78) |
| Male | ||||
| ICD mean survival | 8.52 (0.73) | 9.04 (0.81) | 8.72 (0.75) | 11.00 (1.03) |
| AAD mean survival | 6.79 (0.73) | 7.13 (0.82) | 5.80 (0.78) | 7.31 (1.14) |
| Life years gained | 1.73 (0.47) | 1.91 (0.52) | 2.91 (0.58) | 3.69 (0.74) |
| Female | ||||
| ICD mean survival | 10.11 (1.95) | 9.87 (2.14) | 9.96 (1.97) | 14.54 (3.25) |
| AAD mean survival | 8.22 (1.66) | 7.92 (1.81) | 6.85 (1.61) | 9.87 (3.14) |
| Life years gained | 1.89 (0.62) | 1.95 (0.65) | 3.11 (0.76) | 4.67 (1.05) |